Objective: Absorption of stearic acid from natural oils has been shown to be efficient, but it is claimed to be lower from shortand long-acyl-chain triacylyglycerol molecules (Salatrim). The aim was to measure the apparent absorption of stearic acid from Salatrim fat in an acute test meal. Design: Double-blind crossover study. Subjects: Ten healthy male volunteers, of whom eight completed the study. Methods: The subjects were studied on two occasions after consumption of a single high-fat meal either without (control) or with 30 g of Salatrim. Fecal samples were collected for 96 h after the meal and the fat was extracted for analysis of the content and composition of free and esterified long-chain fatty acids. Results: Baseline fecal fat was 5.672.6 g/day increasing to 10.474.9 g/day after addition of Salatrim (P ¼ 0.001). During the whole collection period, the baseline fecal free and esterified fatty acids were 2.672.3 and 0.870.7 g, respectively. After Salatrim meal the corresponding figures increased to 5.973.6 g (P ¼ 0.001) and 1.5 (71.2) g (P ¼ 0.003), respectively. The total fecal stearic acid after control meal was 0.9770.9 g. Consumption of Salatrim with 16.770.5 g of stearic acid increased the content to 3.1271.6 g (Po0.001), with apparent absorption of 87%. Conclusions: The apparent absorption of stearic acid does not differ from its absorption from natural fats. The status of Salatrim as a low-energy fat substitute needs to be re-evaluated. Sponsorship: University of Turku.
Introduction
Structured triacylglycerols with short and long acyl chains (Salatrim) are being used as reduced calorie fat in confectionary and bakery products. In each Salatrim molecule there is at least one short-chain fatty acid and at least one longchain saturated fatty acid (usually stearic acid) (Anonymous, 2002a) . The claim of a reduced caloric content is based on the properties of the components: on the lower combustible energy derived from the short-chain acetic, propionic and butyric acids (3.5, 5.0 and 6.0 kcal/g) compared with conventional long-chain fatty acids (e.g., stearic acid 9 kcal/g, respectively) (Weast, 1993) and on the claimed reduced absorption of saturated long-chain stearic acid (Hayes et al., 1994) .
The early suggestions of low absorption of stearic acid (Mattson, 1959; Mattson et al., 1979) have recently been questioned. The absorption of stearic acid from natural fats and oil is currently estimated to lie between 86 and 98% (Denke and Grundy, 1991; Dougherty et al., 1995; Baer et al., 2003) . This is in conflict with the reported 63% absorption of stearic acid from Salatrim .
It is possible that in Salatrim, the combination of shortand long-chain fatty acids in the same molecule results in only a partial hydrolysis by the pancreatic lipase and a formation of poorly digestible mono-and distearoylglycerols (Livesey, 2000) . This could result with partially hydrolyzed Salatrim molecules with esterified stearic acid excreted in the feces. The aim of this study was to measure the apparent absorption of stearic acid from Salatrim consumed with a high-fat meal, and to measure the distribution of stearic acid between the free and the esterified fractions.
Subjects and methods

Subjects
Ten healthy males were recruited for the study. The exclusion criteria included a family history of cardiovascular disease or diabetes, body mass index (BMI) o19 or 425, plasma cholesterol 45.0 mmol/l, plasma triacylglycerol 42.0 mmol/l, current use of prescription drugs and an immoderate consumption of alcohol. The mean values and s.d. for clinical data of the subjects were: age 19.971.6 (years); BMI 21.270.6 (kg/m 2 ); triacylglycerols 0.870.3 (mmol/l); cholesterol 3.770.3 (mmol/l); s-HDL 1.470.2 (mmol/l); s-LDL 2.070.4 (mmol/l). One subject was not able to participate in one test period for personal reasons not related to the study and one subject showed a deviating pattern in the fecal fat excretion, resulting with eight subjects included in the final data. Informed consent was obtained from each participant. The study protocol was approved by the Ethical Committee of the University Hospital of Turku, Finland.
Study design
The study had a non-randomized, double-blind cross-over design. Fecal fat content and composition after two meals consisting of either hamburgers (control test meal, period 1) or hamburgers combined with 30 g of Salatrim (Benefat B-R, Danisco, Copenhagen, Denmark) (Salatrim test meal, period 2) were measured on two occasions 4 weeks apart.
The controlled diet was started on day 1 at noon. The evening meal was consumed at 2000 h. On day 2, the subjects attended the trial site at 0800 h after a 12-h fast. Adherence to the instructions was checked verbally. The test meal was consumed within 10 min, after which the subjects abstained from all food (water allowed). A pizza meal was served 7.5 h later, after which the subjects were free to leave. The controlled diet was continued until the end of day 2. Gastrointestinal tolerance was surveyed with a questionnaire.
Diet and test meals
The controlled diet consisted of frozen pizzas (Lännen Tehtaat, Säkylä, Finland and Dr Oetker, Bielefeld, Germany) obtained from a local grocery store and test meals. The pizzas were screened to make sure they had a roughly equal carbohydrate-to-fat ratio. Two subjects who did not have sufficient cold storage were provided with non-frozen readyto-eat pizzas with similar nutritional content. Food was provided on an ad libitum basis, but the subjects were advised to follow their normal eating habits with respect to eating times and amount consumed. Drinking was not controlled except for alcohol (not allowed during the test period).
The test meal hamburgers (mean weight 324712 g) were obtained from a fast-food restaurant (Hesburger, Turku, Finland) ready to eat. About 1,0080 IU vitamin D (Devitol, Orion, Turku, Finland) in 5.0 g of soybean oil was added to both meals to study vitamin D absorption (results not presented here) and Salatrim fat was spread on hamburger buns at Salatrim test. Hamburgers were heated in a microwave oven before consumption.
Representative samples of the controlled diet (pizzas and hamburgers) were pooled separately, homogenized and freeze-dried for subsequent protein, carbohydrate and fat analyses. Protein was analyzed by the Kjeldahl method using correction factor of 6.25. Available carbohydrate was analyzed with an enzymatic kit (Megazymes, Bray, Ireland) and lipids were chloroform-extracted from lyophilized samples with Soxhlett. Test meal lipids and long-chain fatty acids were analyzed in the same way as from the fecal samples.
Fecal samples
The subjects collected fecal samples from 0800 h on day 2 for a maximum of 96 h. A coloring agent was used for estimating transit time. Quantitative samples were collected with the Kendall Precision Commode Specimen Collection System (Tyco Healthcare, Helsinki, Finland). Samples were frozen and stored at À201C. Feces were lyophilized, transferred to plastic bags and thoroughly homogenized after crushing.
A representative sample of lyophilized feces (13 g, 9-37% of total feces) from the transit time period (varying between 24 and 96 h) was first Soxhlett-extracted with chloroform for 5 h, then acidified with HCl, lyophilized and extracted again for another 5 h. Total lipid yield was measured gravimetrically. The extractability of the Salatrim fat was checked with a spiked sample. Internal standard (triheptadecanoate, Sigma, St Louis, MO, USA) for quantification was added to both extracts. The esterified fatty acids were analyzed by methylation of the first extract by sodium methoxide (Christie, 1982) , and total fatty acids by methylation of both extracts by boron trifluoride (Morrison and Smith, 1964) . The methyl esters were analyzed by gas chromatography with a flame ionization detector (Perkin-Elmer Autosystem, Boston, MA, USA) with a J&W DB23 column (60 m Â 0.32 mm i.d., 0.25 mm film (Agilent, Folsom, CA, USA)). Non-esterified fatty acids were calculated by subtracting the esterified from the total fatty acids.
Excreted fecal lipids were first measured from the whole sample collection period, which varied individually and were then expressed as g/day by dividing total yield by collection time. The absorption of stearic acid from Salatrim was calculated by subtracting the control period fat excretion (g/day) from the Salatrim period fat excretion (g/day), multiplied by sample collection time.
Statistical analysis
Each subject consumed two test meals in non-random order, and served as his own control. Paired samples t-test was used for testing the differences in fecal fat, total, esterified and non-esterified fatty acid fractions, and individual fatty acids. A statistical difference at Po0.05 was deemed significant. Analyses were carried out with SPSS (Chicago, IL, USA). Values are expressed as the mean of eight determinations. All data were log-transformed before analysis.
Results
Diet
The nutrient composition of the controlled diet is presented in Table 1 . During the control period, the dietary fat was estimated to consist of 29% saturated (SFA), 50% monounsaturated (MUFA) and 21% polyunsaturated fatty acids (PUFA) with palmitic (19%), stearic (6%), oleic (47%), linoleic (15%) and a-linolenic (5%) acids as the major fatty acids. During the Salatrim period, SFA, MUFA and PUFA content were 34, 46 and 20%, respectively, with 18% palmitic, 13% stearic, 43% oleic, 14% linoleic and 5% a-linolenic acids. In 30 g of Salatrim, 1.270.0 g (5.770.2% of all long-chain fatty acids) palmitic acid, 16.770.5 g (76.670.9%) stearic acid, 2.070.1 g (9.370.1%) oleic acid and 0.770.0 g (3.070.1%) linoleic acid were measured, with a total 21.870.9 g of long-chain fatty acids (72.873.0% of Salatrim net weight). The total test meal fat composition is shown in Table 2 .
Fecal fat
The gastrointestinal transit time varied between 1 and 3 days and did not differ between the test meals. After the Salatrim meal, the fecal fat content increased in all but one subject, whose daily fecal fat content decreased by 1.2 g. The subject's defecation frequency was very low and the fecal weight was high after the Salatrim meal, indicating long transit time. The fatty acid profile of the fecal samples (collected for 96 h), however, showed an increase in the stearic acid content, similar with other subjects after the Salatrim meal. Even though the subject's fecal weight, fecal fat content and defecation frequency were normal after the control meal, a possibility of temporary gastrointestinal disturbance could not be screened out, and the subject's data was excluded from the analysis as a precaution.
The total lipids and esterified and non-esterified fatty acids from the whole fecal collection period are presented in Table 3 . The free and esterified fatty acids increased significantly after the Salatrim meal (increase of 128% (P ¼ 0.001) and 88% (P ¼ 0.003), respectively). Unsaponifiables (excluding fatty acids) accounted for 69.5 and 61.1% of the lipid extracts from control and Salatrim periods, respectively.
The average fecal total lipid content after the control test meal was 5.672.6 g/day and it increased to 10.472.9 g/day after the Salatrim test meal (P ¼ 0.001). During the whole collection period, ingestion of a single 30 g dose of structured triacylglycerol increased the total fecal-fat content by 8.274.9 g (P ¼ 0.001).
Fecal fatty acids
The fecal fatty acid composition is shown in Table 4 . After the control test meal, the major fecal fatty acids were Consumption of 30 g of Salatrim increased the amount of all the major fatty acids in the feces. The increase in palmitic and stearic acids were mainly in free form (0.9670.9 g (P ¼ 0.005) and 1.9271.0 g (Po0.001)). A minor, but significant, increase of them was observed in the esterified fatty acids fraction. Oleic acid increased in both free and esterified form (0.2170.2 g (P ¼ 0.015) and 0.2470.4 g (not significant)), whereas linoleic acid increased almost exclusively in esterified form (0.1470.2 g (not significant)). Figure 1 presents the major fatty acids in the free and esterified fractions.
The fatty acid profiles of the additional fecal fat after Salatrim differed clearly between the free and esterified fractions. Stearic and palmitic acids dominated in the free fatty acids, covering nearly 60% and nearly 30% of the increase, respectively. Among the esterified fatty acids, the distribution was more even. Stearic acid (38.1% of the additional esterified fatty acids) was still the major compound, but also unsaturated oleic (30.5%) and linoleic acids (19.1%) increased substantially.
Apparent absorption of stearic acid
The addition of 30 g of structured triacylglycerol with 16.7 g of stearic acid increased the test meal stearic acid content over five-fold and more than doubled the stearic acid intake during the 48-h test period (the test day and the preceding day). After the Salatrim meal, ca. 2 g more stearic acid was found in the feces and the apparent absorption of the stearic acid from Salatrim was 87.2%. Compared with the control, the subjects did not report more gastrointestinal events after the Salatrim meal. 
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Discussion
Absorption of Salatrim
It has been claimed that only 2/3 of the stearic acid of Salatrim is absorbed owing to formation of insoluble calcium and magnesium stearate after the triacylglycerol hydrolysis (Hayes et al., 1994) . It has also been proposed that the reduced availability from Salatrim may result from the high stearic acid density in the triacylglycerol molecule (Livesey, 2000) . We investigated the absorption of stearic acid by measuring the fecal fat content after ingestion of a single 30 g dose of Salatrim with a high-fat meal. We found that the stearic acid content increased significantly by 2.15 g, indicating an apparent absorption of stearic acid from Salatrim of 87.2%. Only 10.4% of the fecal stearic acid was esterified, disproving the hypothesis of reduced lipolysis of Salatrim.
The design of our study, in which Salatrim was added to the control meal resulting in differing fat contents in the control and the Salatrim test meals, may have had some effect on the absorption process. We chose not to replace a portion of the fat of the control meal with Salatrim because of the impossibility of defining an equivalent portion of conventional and Salatrim fats. In principle, the substituted portions could be similar in either total lipophilic matter, long-chain fatty acids or energy (kJ); all these are different in terms of weight, and the use of any of them would have made the interpretation of the results more complicated. Therefore, we opted for the simple design, in which the control was supplemented with Salatrim. As no reports can be found describing a clear and significant effect of fat dose on fat absorption, we do not believe that the difference in fat content has had a significant effect on the results.
To our knowledge, only one human study on the fecal excretion of stearic acid after consumption of Salatrim fat has been published. As a part of the original introduction of Salatrim, reported the fecal excretion of fat after Salatrim exposure. These results are in stark contrast to ours: the earlier study reported that over a third of Salatrim was excreted, whereas we found only 13% of the ingested stearic acid in the feces.
It is clear that the single-dose methodology does not achieve the accuracy of longer exposure to test fat, but it is also evident that differences in study protocols do not suffice for explaining the conflicting results. One source for variation could be the Salatrim compositions used; the earlier study used Salatrim 23CA, where acetic and propionic acid accounted for 22.5 and 3.2 wt% of the total fatty acids, respectively. In the present study, acetic acid was the only short-chain fatty acid present. Stearic acid content was ca 57% in both Salatrim fats. With our current limited knowledge of the metabolism of Salatrim fats in humans, it is not possible to estimate whether the differences in short-chain fatty acids could be responsible for the differences in absorption. Another difference might lie in the stearic acid concentration of the test meals. In a rat study, an inverse relation was found between the test fat stearic acid concentration and its energy value (Treadwell et al., 2002) , possibly owing to fat crystallization at high stearic acid concentration. Consumption of Salatrim fat with conventional fats (as in our study) could thus result with enhanced absorption of stearic acid.
Fecal lipid content and composition
With healthy young subjects on a typical Western diet the gastrointestinal transit time has generally been o3 days (Wyman et al., 1976; Stasse-Wolthuis et al., 1980; Eastwood et al., 1986; Haack et al., 1998) or o2 days (Muir et al., 2004) . In the present study, the detected transit times were very short (38714 h) and the defecation frequency high (1.070.4 times per day). Whenever there was no detectable color, the feces were analyzed for at least 72 h. We are confident that the collection time was sufficient for unabsorbed stearic acid defecation.
Little systematic work has been conducted on the composition of fecal lipids. In some early studies, fatty acids (free or esterified) were thought to comprise the whole of the lipid extract, resulting in gross overestimation of fecal fatty acid losses. Carey et al. (1983) report that fatty acids and their soaps account for 80% of the fecal lipids, but in 1991 Denke and Grundy (1991) noted that the fatty acids can be overestimated by 100% if they are quantified without internal standard.
Crude fat excretion of healthy men on various experimental diets (based mostly on natural triacylglycerols or their transesterified products) has generally varied between 4 and 12 g/day (Carey et al., 1983; Mitchell et al., 1989; Shahkhalili et al., 2000) . The proportion of fatty acids (free, soaps or derived from acylglycerols) of the total lipids has rarely been reported, but the fatty acid concentration in feces has been between 0.2 and 6 g/day (Bonanome and Grundy, 1988; Denke et al., 1993) , typically 2-4 g/day (see e.g. Denke and Grundy, 1991; Dougherty et al., 1995; Snook et al., 1999) . In the present study, crude fat excretion was at the expected level. The amount of fatty acids in the feces (g/day) was in line with earlier investigations, but their proportion in the total lipid extract was lower. This is most likely a result of the extraction method, which is efficient for both nonpolar and polar lipids. Preliminary analysis of the esterified fatty acids suggests that they are mostly present in acylglycerols.
The differences in the fatty acid profiles in the free and the esterified fractions after Salatrim are interesting (Figure 1) . the increase in fecal free fatty acids resembles the profile of Salatrim fat, whereas the increase in esterified fatty acids bears a similarity with that of the whole Salatrim test meal. The dominating role of palmitic and stearic acids among the free fatty acids supports the view that once hydrolyzed, saturated long-chain fatty acids more easily remain unabsorbed. A substantial portion of the esterified fatty acids in feces is probably derived from the poorly absorbed trisaturated triacylglycerols of the Salatrim fat (Livesey, 2000) .
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Calculated from the manufacturer's information, the theoretical proportion of triacylglycerols with three saturated long-chain fatty acids is 3.3% (ca.1.0g per Salatrim test meal).
Absorption of stearic acid
There are a number of studies in which different types of stearic acid-rich fats have resulted in poor absorption. However, in well-controlled dietary intervention studies, the absorption has been just marginally lower than that of the other fatty acids. Three factors are probably responsible for the variation. First, in the early studies, tristearin was used as the stearic acid source (e.g. Arnschink, 1890; Mattson, 1959; Mattson et al., 1979) . With a melting point of 731C (Small, 1991) , tristearin is poorly emulsified and digested. It has been shown that concurrent melting, emulsification and mixing with low melting point fats dramatically increases tristearin absorption (Hashim and Babayan, 1978; Emken, 1994) . Further support for the importance of melting point can be found from postprandial lipemia studies, where the transesterified fats with similar fatty acid composition but higher melting points than their natural counterparts, showed significantly lower plasma lipid concentration (Sanders et al., 2003; Berry and Sanders, 2005) , which is an indication of lower or slower absorption.
Secondly, many earlier studies used an animal model, most often rat. Later, it has been stated that 'the rat is not a good model for humans with respect to stearic acid absorption' (Benford et al., 2002) , simply because the results in rats differ from those in humans. There are several reasons for this, but a good point was made by Shahkhalili et al. (2000) when they compared the calcium:fat ratios in typical rodent and human diets: the ratio is 4-18 times higher in the rodent diet. If calcium soaps do have a role in the excretion of free stearic acids, this must be of much greater importance in the rat. Also in the study by there was a clear discrepancy between the measured absorption of stearic acid in rats (29-32% and humans (64-72%)). Thirdly, if the concentration of stearic acid within the dietary fat does influence stearic acid absorption, as suggested (Treadwell et al., 2002) , a plausible explanation would be the higher stearic acid concentration used in the rat studies, which is simply unfeasible in human trials (and in human diet in general).
Salatrim is a synthetic, randomized triacylglycerol consisting mostly of mono-and diacetostearines, and with a minor proportion of poorly digested tristearate. It has been suggested that in the mono-and diacetostearines, shortchain acetic acid is favorably hydrolyzed , producing a high melting point and poorly digestible di-and monostearoylglycerols (Livesey, 2000) . In the present study, this hypothesis was shown to be untenable. We also showed that the total (free and esterified) fecal stearic acid loss from Salatrim is not significantly different from that reported for other stearic acid-rich fats. The atypical structure of Salatrim fats with short-and long-chain fatty acids esterified in the same glycerol backbone does not influence the degree of absorption of the long-chain fatty acids.
In its 59th meeting, the JECFA stated that no conclusions can be drawn about the caloric value of Salatrim from the data presented to the committee (Anonymous, 2002b) . In contrast, based on the opinion of the Scientific Committee on Food, the European Union has recently approved Salatrim as a reduced calorie fat with a caloric value of 5-6 kcal/g (Anonymous, 2003 (Anonymous, , 2002c . The conflicting results from the few available human absorption studies with Salatrim, together with the fact that stearic acid from conventional fats is well absorbed, call for a serious reevaluation of the caloric value of Salatrim.
